Product Information
Applications
Biological Information
Primary TargetD₂
Purity≥99% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity Standard Handling
Storage +2°C to +8°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications

Documentation

(S)-(-)-Raclopride - CAS 84225-95-6 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

References

Reference overview
Dang, Y. H. et al. 2010. Neurosci. 169, 1872.
Platt, D. M. et al. 2010. J. Pharmacol. Exp. Ther. 332, 985.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision12-September-2013 JSW
SynonymsDopamine Receptor D2 Antagonist, (S)-Raclopride, Raclopride
DescriptionD2-like dopamine receptor antagonist targeting D2R (pKi =8.0), D3R (pKi = 7.9), and 5-HT1A R (pKi=5.2). Used to explore D2 like receptor mediated effects in neuropathic pain, and in antagonism studies of DA receptors during heroin usage and cocaine. D2 Receptor selectivity in various preps shows IC50 values around 32 nM.
FormOff-white solid
CAS number84225-95-6
Chemical formulaC₁₅H₂₀Cl₂N₂O₃
Structure formulaStructure formula
Purity≥99% by HPLC
SolubilityDMSO (100 mM) or Ethanol (25 mM)
Storage +2°C to +8°C
Protect from light
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Standard Handling
ReferencesDang, Y. H. et al. 2010. Neurosci. 169, 1872.
Platt, D. M. et al. 2010. J. Pharmacol. Exp. Ther. 332, 985.

Related Products & Applications

Categories

Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Neurochemicals > Antagonists > Dopaminergic Receptor Antagonists